“Many people believe that the most frequently washed body part in 2020-21 was the hands, but in reality; it was the BRAIN.” - Bhushan Mahadani
Yes, that is certainly true. It changed not only Pfizer but all of us. Forever.
The pressure is now on Bourla to come up with the next blockbuster drug. And we will all be expected to take it. Some of us will refuse. But how many of us can say that at some point in our lives we have not fallen under the spell of a drug company and the promises they gave us?
Bourla is facing the biggest challenge of his career. Not only are the heady days of billion-dollar profits from Covid vaccines and Paxlovid winding down, but Pfizer is set to lose up to $18 billion in revenue from 2025 through 2030 as it loses several key patents.
If you are the CEO of Pfizer, with a salary of $24.3 million for 2021, equity holdings of nearly 597,000 shares worth more than an estimated $32 million and are entitled to a golden parachute of nearly $113 million, you better believe you are going to have to up your game over the next few years if you are going to keep your shareholders happy.
Upping its game will not be easy for Pfizer since the Covid vaccine, with its “groundbreaking technology”, has been the largest selling pharmaceutical product in history.
In just the first three months of 2021, Pfizer made $3.5 billion from the Covid vaccine.Pfizer went on to make a staggering $36.8 Billion in 2021. It expects revenue of $29 billion in 2022. This despite recently admitting that the vaccine does not stop transmission, nor does it stop people from getting sick. The company expects to make at least $22 billion from Paxlovid, the drug that causes “Covid rebound”.
To read more please go to Why Everyone Must Get Sicker for the Good of Pfizer (substack.com)
